Global Blood: 2Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Global Blood Therapeutics Inc. (GBT) on Wednesday reported a loss of $57.3 million in its second quarter.
The South San Francisco, California-based company said it had a loss of $1.01 per share.
The results did not meet Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.
Global Blood shares have climbed 21% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $49.59, an increase of nearly 6% in the last 12 months.